2001•Unpublished venueRequires access

Clinical observation of ineglumine cyclic adenylate(MCA) injection in treating patients with congestive heart failure

Min Lu

Abstract

Objective:To observe the efficacy and safety of MCA on patients with congestive heart failure(CHF).Method:A randomized,Single-blind,contrast-controlled study was performed.Before and after the treatment,heart functions of both groups were measured by color Dopple echocardiography,the blood pressure and heart rate were investigated,the clinical symptoms,singns and the side effects were also observed.Result:The treatment efficiencies of MCA group and contrast group were 90.7% and 70.6% respectively,( P 0.05) and no serious side effects occurred in MCA group.Conclusion:The MCA was clearly better than routine treatment,MCA was an effective and safe drug for the patients with CHF.

About this research paper

What this paper is about

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Key concepts: Medicine, Heart failure, Cardiology, Internal medicine, Heart rate, Blood pressure